Tamoxifen [orch, phsu]
Cardiac [bpoc]
risk factors [qnco]
Health [idcn]
Women [popg]
Suggestion [idcn]
Anti-inflammatory effect [qlco]
Tamoxifen [orch, phsu]
Breast Cancer [neop]
Women [popg]
At risk [qlco]
Heart disease [dsyn]
Leading [tmco]
Women [popg]
Tamoxifen [orch, phsu]
Venous Thrombosis [patf]
Improved [qlco]
Understanding [menp]
Association [menp]
Tamoxifen [orch, phsu]
cardiovascular risk factor [dsyn]
Required [ftcn]
III [inpr]
Health [idcn]
Women [popg]
Single [popg]
Center [spco]
Participating [ftcn]
randomized [resa]
DOUBLE BLIND [resa]
Breast Cancer Prevention Trial [resa]
effects [qlco]
Oral [spco]
Tamoxifen [orch, phsu]
mg/d [qnco]
Compared [acty]
placebo [topp]
Inflammation [patf]
Haemostasis [ortf]
Lipids [lipd]
Study [mnob]
Tamoxifen [orch, phsu]
reductions [npop]
C-reactive protein [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
Cholesterol [bacs, strd]
P NOS [aapp, imft]
Compared [acty]
placebo [topp]
Treatment Effect [fndg]
factor VII coagulant activity [aapp, imft]
fragment [ftcn]
Triglycerides [bacs, lipd]
secondary [neop]
Tamoxifen [orch, phsu]
C-reactive protein [aapp, imft]
larger [qnco]
postmenopausal [tmco]
Women [popg]
Women [popg]
Waist-to-Hip Ratios [orga]
Fibrinogen [aapp, bacs, phsu]
larger [qnco]
Women [popg]
high cholesterol [fndg]
baseline [bodm]
Tamoxifen [orch, phsu]
effects [qlco]
Inflammatory [ftcn]
Marker [clna]
Consistent [idcn]
Reduced [qlco]
CARDIOVASCULAR [bdsy]
findings [ftcn]
Reports [inpr]
Increased C-reactive protein [fndg]
postmenopausal [tmco]
Estrogen [horm, phsu, strd]
CARDIOVASCULAR [bdsy]
Tamoxifen [orch, phsu]
Health [idcn]
Women [popg]
Suggest [idcn]
